Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of Three Forms of Pegfilgrastim in Healthy Volunteers
NCT02205320Phase 1Unknown
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Feb 2014
- Primary completion
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of pegfilgrastim in neutropenia (6 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoints: Maximum Plasma Concentration at 105 days, Area Under the Curve from time zero to infinity at 105 days and 3 more. Status: unknown.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT02205320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205320.